Asymchem, a global CDMO, has appointed Franck Mevellec as senior director, business development. Mevellec brings over 20 years of experience in the pharmaceutical industry, working across various aspects of drug development from R&D to sales.   Mevellec boasts a track record of success, having held key positions at industry leaders like Bayer Healthcare (R&D), Teva Pharmaceuticals (portfolio director), Minakem (BD director), and most recently, Seqens (global head of sales). He joins As...